[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Special Article
June 26, 2000

Practical Guidelines for Clinicians Who Treat Patients With Amiodarone

Nora Goldschlager, MD; Andrew E. Epstein, MD; Gerald Naccarelli, MD; et al Brian Olshansky, MD; Braman Singh, MD; for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology
Author Affiliations

From the Cardiology Division, University of California, San Francisco, San Francisco General Hospital.

Arch Intern Med. 2000;160(12):1741-1748. doi:10.1001/archinte.160.12.1741
Abstract

Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.

×